Stem cell-mediated delivery of therapies in the treatment of glioma

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 7, 2011, Pages 591-598

  Frosina, G ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cancer; Gene therapy; Glioma; Resistance; Stem

Indexed keywords

ALPHA INTERFERON; ANGIOPOIETIN RECEPTOR; BETA INTERFERON; CONNEXIN 43; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2B6; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 12; LENTIVIRUS VECTOR; NANOPARTICLE; PARVOVIRUS VECTOR; RED FLUORESCENT PROTEIN; SECRETABLE TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; THYMIDINE KINASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL CHROMOSOME; BYSTANDER EFFECT; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; GLIOBLASTOMA; GLIOMA; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MONOCYTE; NANOTECHNOLOGY; NEURAL STEM CELL; NONHUMAN; STEM CELL; SUICIDE GENE THERAPY; TROPISM; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; STEM CELLS; TROPISM;

EID: 79959980398     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711795906897     Document Type: Article

References (43)

1. Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. Exciting new advances in neuro-oncology:The avenue to a cure for malignant glioma. CA Cancer. J. Clin., 2010, 60, 166-193.
2. Jeon, J. Y.; An, J. H.; Kim, S. U.; Park, H. G.; Lee, M. A. Migration of human neural stem cells toward an intracranial glioma. Exp. Mol. Med., 2008, 40, 84-91.
3. Jurvansuu, J.; Zhao, Y.; Leung, D. S.; Boulaire, J.; Yu, Y. H.; Ahmed, S.; Wang, S. Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Cancer Res., 2008, 68, 4614-4622.
4. Gutova, M.; Najbauer, J.; Frank, R. T.; Kendall, S. E.; Gevorgyan, A.; Metz, M. Z.; Guevorkian, M.; Edmiston, M.; Zhao, D.; Glackin, C. A.; Kim, S. U.; Aboody, K. S. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells, 2008, 26, 1406-1413.
5. Kendall, S. E.; Najbauer, J.; Johnston, H. F.; Metz, M. Z.; Li, S.; Bowers, M.; Garcia, E.; Kim, S. U.; Barish, M. E.; Aboody, K. S.; Glackin, C. A. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells, 2008, 26, 1575-1586.
6. Achanta, P.; Sedora Roman, N. I.; Quinones-Hinojosa, A. Gliomagenesis and the use of neural stem cells in brain tumor treatment. Anticancer Agents Med. Chem., 2010, 10, 121-130.
7. Kosztowski, T.; Zaidi, H. A.; Quinones-Hinojosa, A. Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev. Anticancer Ther., 2009, 9, 597-612.
8. Xu, Q.; Yuan, X.; Xu, M.; McLafferty, F.; Hu, J.; Lee, B. S.; Liu, G.; Zeng, Z.; Black, K. L.; Yu, J. S. Chemokine CXC receptor 4-mediated glioma tumor tracking by bone marrow--derived neural progenitor/stem cells. Mol. Cancer. Ther., 2009, 8, 2746-2753.
9. Oh, M. C.; Lim, D. A. Novel treatment strategies for malignant gliomas using neural stem cells. Neurotherapeutics, 2009, 6, 458-464.
10. Ehtesham, M.; Kabos, P.; Gutierrez, M. A.; Chung, N. H.; Griffith, T. S.; Black, K. L.; Yu, J. S. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factorrelated apoptosis-inducing ligand. Cancer Res., 2002, 62, 7170-7174.
11. Ehtesham, M.; Kabos, P.; Kabosova, A.; Neuman, T.; Black, K. L.; Yu, J. S. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res., 2002, 62, 5657-5663.
12. Mercapide, J.; Rappa, G.; Anzanello, F.; King, J.; Fodstad, O.; Lorico, A. Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Int. J. Cancer, 2010, 126, 1206-1215.
13. Ito, S.; Natsume, A.; Shimato, S.; Ohno, M.; Kato, T.; Chansakul, P.; Wakabayashi, T.; Kim, S. U.: Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther., 2010, 17, 299-306.
14. Huang, Q.; Liu, X. Z.; Kang, C. S.; Wang, G. X.; Zhong, Y.; Pu, P. Y. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther., 2010, 17, 192-202.
15. Lee, D. H.; Ahn, Y.; Kim, S. U.; Wang, K. C.; Cho, B. K.; Phi, J. H.; Park, I. H.; Black, P. M.; Carroll, R. S.; Lee, J.; Kim, S. K. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin. Cancer Res., 2009, 15, 4925-4934.
16. Rath, P.; Shi, H.; Maruniak, J. A.; Litofsky, N. S.; Maria, B. L.; Kirk, M. D. Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas. Curr. Stem Cell. Res. Ther., 2009, 4, 44-49.
17. Zhao, Y.; Wang, S. Human NT2 neural precursor-derived tumorinfiltrating cells as delivery vehicles for treatment of glioblastoma. Hum. Gene Ther., 2010, 21, 683-694.
18. Kim, J. H.; Lee, J. E.; Kim, S. U.; Cho, K. G. Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma. Neurosurgery, 2010, 66, 333-342; discussion 342.
19. An, J. H.; Lee, S. Y.; Jeon, J. Y.; Cho, K. G.; Kim, S. U.; Lee, M. A. Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J. Proteome Res., 2009, 8, 2873-2881.
20. Ziu, M.; Schmidt, N. O.; Cargioli, T. G.; Aboody, K. S.; Black, P. M.; Carroll, R. S. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J. Neurooncol., 2006, 79, 125-133.
21. Widera, D.; Holtkamp, W.; Entschladen, F.; Niggemann, B.; Zanker, K.; Kaltschmidt, B.; Kaltschmidt, C. MCP-1 induces migration of adult neural stem cells. Eur. J. Cell Biol., 2004, 83, 381-387.
22. Magge, S. N.; Malik, S. Z.; Royo, N. C.; Chen, H. I.; Yu, L.; Snyder, E. Y.; O'Rourke, D. M.; Watson, D. J. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J. Neurosci. Res., 2009, 87, 1547-1555.
23. Ayuso-Sacido, A.; Moliterno, J. A.; Kratovac, S.; Kapoor, G. S.; O'Rourke, D. M.; Holland, E. C.; Garcia-Verdugo, J. M.; Roy, N. S.; Boockvar, J. A. Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J. Neurooncol., 2010, 97, 323-337.
24. Kabos, P.; Ehtesham, M.; Kabosova, A.; Black, K. L.; Yu, J. S. Generation of neural progenitor cells from whole adult bone marrow. Exp. Neurol., 2002, 178, 288-293.
25. Kinoshita, Y.; Kamitani, H.; Mamun, M. H.; Wasita, B.; Kazuki, Y.; Hiratsuka, M.; Oshimura, M.; Watanabe, T. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells. Neurol. Res., 2010, 32, 429-437.
26. Menon, L. G.; Kelly, K.; Yang, H. W.; Kim, S. K.; Black, P. M.; Carroll, R. S. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells, 2009, 27, 2320-2330.
27. Yang, B.; Wu, X.; Mao, Y.; Bao, W.; Gao, L.; Zhou, P.; Xie, R.; Zhou, L.; Zhu, J. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing ligand-engineered human mesenchymal stem cells. Neurosurgery, 2009, 6, 610-624; discussion 624.
28. Mori, K.; Iwata, J.; Miyazaki, M.; Osada, H.; Tange, Y.; Yamamoto, T.; Aiko, Y.; Tamura, M.; Shiroishi, T. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells. Neurol. Med. Chir., (Tokyo) 2010, 50, 545-553.
29. Ahmed, A. U.; Rolle, C. E.; Tyler, M. A.; Han, Y.; Sengupta, S.; Wainwright, D. A.; Balyasnikova, I. V.; Ulasov, I. V.; Lesniak, M. S. Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model. Mol. Ther., 2010, 18, 1846-1856.
30. Ahmed, A. U.; Alexiades, N. G.; Lesniak, M. S. The use of neural stem cells in cancer gene therapy: Predicting the path to the clinic. Curr. Opin. Mol. Ther., 2010, 12, 546-552.
31. Yong, R. L.; Shinojima, N.; Fueyo, J.; Gumin, J.; Vecil, G. G.; Marini, F. C.; Bogler, O.; Andreeff, M.; Lang, F. F. Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res., 2009, 69, 8932-8940.
32. Roger, M.; Clavreul, A.; Venier-Julienne, M. C.; Passirani, C.; Sindji, L.; Schiller, P.; Montero-Menei, C.; Menei, P. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010, 31, 8393-8401.
33. Ho, I. A.; Chan, K. Y.; Ng, W. H.; Guo, C. M.; Hui, K. M.; Cheang, P.; Lam, P. Y. Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells, 2009, 27, 1366-1375.
34. Hata, N.; Shinojima, N.; Gumin, J.; Yong, R.; Marini, F.; Andreeff, M.; Lang, F. F. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery, 2010, 66, 144-156; discussion 156-7.
35. Gondi, C. S.; Veeravalli, K. K.; Gorantla, B.; Dinh, D. H.; Fassett, D.; Klopfenstein, J. D.; Gujrati, M.; Rao, J. S. Human umbilical cord blood stem cells show PDGF-D-dependent glioma cell tropism in vitro and in vivo. Neuro Oncol., 2010, 12, 453-465.
36. Xu, F.; Shi, J.; Yu, B.; Ni, W.; Wu, X.; Gu, Z. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol. Rep., 2010, 23, 1561-1567.
37. Egea, V.; von Baumgarten, L.; Schichor, C.; Berninger, B.; Popp, T.; Neth, P.; Goldbrunner, R.; Kienast, Y.; Winkler, F.; Jochum, M.; Ries, C. TNF-alpha respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death Differ., 2010, Dec 3. [Epub ahead of print]
38. Josiah, D. T.; Zhu, D.; Dreher, F.; Olson, J.; McFadden, G.; Caldas, H. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma. Mol. Ther., 2010, 18, 377-385.
39. De Palma, M.; Mazzieri, R.; Politi, L. S.; Pucci, F.; Zonari, E.; Sitia, G.; Mazzoleni, S.; Moi, D.; Venneri, M. A.; Indraccolo, S.; Falini, A.; Guidotti, L. G.; Galli, R.; Naldini, L. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell., 2008, 14, 299-311.
40. Tabatabai, G.; Hasenbach, K.; Herrmann, C.; Maurer, G.; Mohle, R.; Marini, P.; Grez, M.; Wick, W.; Weller, M. Glioma tropism of lentivirally transduced hematopoietic progenitor cells. Int. J. Oncol., 2010, 36, 1409-1417.
41. Ferguson, S. D.; Ahmed, A. U.; Thaci, B.; Mercer, R. W.; Lesniak, M. S. Crossing the boundaries: Stem cells and gene therapy. Discov. Med., 2010, 9, 192-196.
42. Dey, M.; Ulasov, I. V.; Lesniak, M. S. Virotherapy against malignant glioma stem cells. Cancer Lett., 2010, 289, 1-10.
43. Frosina, G. Frontiers in targeting glioma stem cells. Eur. J. Cancer, 2011, 47, 496-507.